Search research articles
Contact Us
Filters
Showing results (171-180 of 249) with videos related to
Page
of 25
Sort By:
International Journal of Molecular Sciences
|
April 30, 2026
RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 10545
Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
Obstetrics & Gynecology Science
|
September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
International Journal of Molecular Sciences
|
July 14, 2023
Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
Journal of Neurochemistry
|
March 11, 2021
AMPK-regulated miRNA-210-3p is activated during ischaemic neuronal injury and modulates PI3K-p70S6K signalling
Shona Pfeiffer, Anna Tomašcová, Uta Mamrak, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
Cancer Treatment and Research Communications
|
April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer
Aoife Carr, Jonathan A Coulter, Julie Workman, et al.
British Journal of Cancer
|
May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
Mattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
EMBO Molecular Medicine
|
December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
Yun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 15, 2013
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer
K I Abdul-Jalil, K M Sheehan, J Kehoe, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 19, 2019
Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea
Andreas U Lindner, Alexa J Resler, Steven Carberry, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 249) with videos related to
Sort By:
Page
of 25
International Journal of Molecular Sciences
|
April 30, 2026
RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 10545
Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
Obstetrics & Gynecology Science
|
September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
International Journal of Molecular Sciences
|
July 14, 2023
Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
Journal of Neurochemistry
|
March 11, 2021
AMPK-regulated miRNA-210-3p is activated during ischaemic neuronal injury and modulates PI3K-p70S6K signalling
Shona Pfeiffer, Anna Tomašcová, Uta Mamrak, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
Cancer Treatment and Research Communications
|
April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer
Aoife Carr, Jonathan A Coulter, Julie Workman, et al.
British Journal of Cancer
|
May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
Mattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
EMBO Molecular Medicine
|
December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
Yun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 15, 2013
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer
K I Abdul-Jalil, K M Sheehan, J Kehoe, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 19, 2019
Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea
Andreas U Lindner, Alexa J Resler, Steven Carberry, et al.
Page
of 25